Studien in der Nachbeobachtung

Adjuvante/neoadjuvante Therapie des frühen Mammakarzinoms

• ALTTO (EudraCT number: 2006-000562-36)
• Aphinity (EudraCT number: 2010-022902-41)
• CBYL719A2201 (EudraCT number: 2013-001862-41)
• CLCL161A2201 (EudraCT number: 2012-000677-23)
• D-Care (EudraCT number: 2009-011299-32)
• Evaluate TM
• Evaluate-Preface (EudraCT number: 2008-004874-42)
• FACE (EudraCT number: 2005-004263-35)
• FEMZONE (EudraCT number: 2004-004007-37)
• GALADON (EudraCT number: 2009-013331-37)
• Genevieve (EudraCT number: 2012-003330-16)
• Geparsixto (EudraCT number: 2011-000553-23)
• HERA (EudraCT number: 2005-002385-11)
• IBIS II- (DCIS) (EudraCT number: 2004-003992-35)
• IBIS II (Prävention) (EudraCT number: 2009-015378-36)
• ICE-Studie ESSBR
• Neo-PHOEBE (EudraCT number: 2012-000738-21)
• Plan B (EudraCT number: 2008-004263-19)
• SafeHer (EudraCT number: 2011-005328-17)

Operative Therapie

• TILoop/ Pfm medical ag
• LifeCell

Lokal fortgeschrittenes und metastasiertes Mammakarzinom

• Abrazo (EudraCT number: 2013-003076-12)
• Alternative (EudraCT number: 2010-019577-16)
• AVADO
• AZD4547 (EudraCT number: 2010-021220-20)
• BERENICE (EudraCT number: 2014-000156-28)
• Biotest 989 (EudraCT number: 2013-003252-20)
• Brightness (EudraCT number: 2013-002377-21)
• Celgene (EudraCT number: 2014-003220-52)
• GDC4950g (EudraCT number: 2010-023763-17)
• EMBRACA (EudraCT number: 2013-002716-28)
• Impassion-130 (EudraCT number: 2014-005490-37)
• Monarch-3 (EudraCT number: 2014-001502-18)
• MonarcHER
• NNBC-3
• PELICAN (EudraCT number: 2005-003164-35)
• PerUse (EudraCT number: 2011-005334-20)
• Pherexa (EudraCT number: 2008-006801-17)
• RADAR (EudraCT number: 2005-005835-87)
• RHEA (EudraCT number: 2004-000572-17)
• TraxHER (EudraCT number: 2012-001547-46)
• TRIO 018 (EudraCT number: 2008-00239-27)
• TRIO 022 (EudraCT number: 2012-004601-27)